Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study

Table 6 Factors associated with anticoagulant therapy in patients with prior stroke

	B	OR (95% CI)	p value
Univariate analysis
Gender, female	0.319	1.376 (0.473~4.004)	0.559
Self-paying	0.360	1.434 (0.401~5.130)	0.580
Age, (per 1 year increase)	0.055	1.057 (1.005~1.112)	0.031
≥ 75 years old	1.107	3.025 (1.001~9.142)	0.050
Education	− 0.279	0.757 (0.220~2.608)	0.659
AF type, Permanent	−0.235	0.791 (0.132~4.726)	0.797
Duration, ≥5 years	−0.276	0.759 (0.259~2.224)	0.615
Severity of symptom	0.882	2.415 (0.499~11.682)	0.273
HAS-BLED, score ≥ 3	−0.706	0.494 (0.167~1.455)	0.200
CHA₂DS₂-VASc, (per 1 score increase)	0.228	1.257 (0.851~1.856)	0.251
Vascular disease	− 0553	0.5752 (0.177~1.870)	0.358
Congestive heart failure	0.205	1.227 (0.120~12.597)	0.863
Diabetes mellitus	0.535	1.708 (0.518~5.631)	0.379
Hypertension	−0.343	0.710 (0.238~2.116)	0.538
Multivariate analysis
Age, (per 1 year increase)	0.073	1.075 (1.016~1.139)	0.013
≥ 75 years old	0.459	1.583 (0.239~10.483)	0.634
Self-paying	0.342	1.407 (0.359~5.515)	0.624
AF type, Permanent	−0.568	0.567 (0.079~4.066)	0.572
Duration, ≥5 years	−0.302	0.739 (0.220~2.481)	0.625
HAS-BLED, score ≥ 3	−1.061	0.346 (0.102~1.175)	0.089

Abbreviations: AF atrial fibrillation, CHA₂DS₂-VASc Congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke, transient ischemic attack, or thromboembolism, vascular disease, age 65–74 years, sex category (female), CI Confidence interval, HAS-BLED Hypertension, abnormal renal and/or liver function, stroke, bleeding history or predisposition, labile international normalized ratio, elderly (age > 65 years), drugs and/or alcohol concomitantly, OR Odds ratio

ISSN: 1471-2261